The pluripotency states of the stem cell are theorized to correlate directly with myocardial restoration potential. However, few studies have conducted head-to-head comparisons of the restorative processes of different stem cell populations and assessed their direct effects on the myocardial viability in vivo. In a comparison study of murine ESCs versus mesenchymal stem cells in postischemic injury, the ESCs demonstrated greater functional recovery when compared with mesenchymal stem cells. 13 The investigation suggested that the greater restorative potential of the ESCs was because of the increased paracrine signaling with enhanced production of vascular endothelial growth factor (VEGF), interleukin (IL)-10 and IGF-1 (insulinlike growth factor) in the ESC-treated hearts. However, the direct effect of paracrine signals on myocardial viability and the biological role of stem cell engraftment were not evaluated.
We examined the therapeutic effects of 3 subpopulations of amniotic mesenchymal stem cells (AMCs) derived from the human placenta. AMCs are derived from the inner cell mass of the embryo, which differentiate into the epiblast and the hypoblast on days 8 to 9 of embryological development. The epiblast gives rise to the extraembryonic mesoderm-like AMCs in the amniotic membrane, which retain pluripotent gene expression. 14 These stem cells differentiate predominantly along the mesodermal lineage and have propensity for cardiac lineage specification by the expression of the ckit + cell surface marker associated with cardiac progenitor cells. 14 In addition, these cells line the amniotic membrane situated at the maternal-fetal interface, conferring the critical immunomodulatory properties for the fetus.
14 Three cell subpopulations were generated from this common lineage to directly compare their therapeutic potential: (1) unselected AMCs (uAMCs), (2) ckit + AMCs (c + AMCs), and (3) AMC-derived induced pluripotent stem cells (MiPSCs). This study hypothesized that the MiPSCs would have the greatest cardiac restorative potential because of their pluripotency.
Manganese-enhanced MRI (MEMRI) enables viabilityspecific evaluation of the myocardium. This novel technique was integrated with delayed-enhanced MRI (DEMRI) to measure the direct therapeutic impact of the stem cells on myocardial viability and to correlate with sensitive in vivo bioluminescence imaging (BLI) of stem cell engraftment. 15, 16 This integrated in vivo imaging platform allowed real-time evaluation of the direct biological effects of the engraftment of AMC derivatives on the viable, injured, and nonviable myocardium volume at high temporal and spatial resolution.
This study demonstrated that myocardial viability paralleled differential engraftment of each AMC subpopulation and correlated with the degree of salvage of the injured myocardium.
Methods
Detailed methods are provided in the Online Data Supplement.
Isolation of AMCs From the Human Placentas
A placenta from 1 healthy subject was obtained. uAMCs were enzymatically isolated from the amniotic membrane.
Fluorescent-Activated Cell Sorting
The uAMCs underwent 2-step fluorescent-activated cell sorting with ckit and SSEA-4 antibodies. The sorted cells were labeled c + AMCs.
BLI Reporter Gene Virus Generation
A BLI reporter gene plasmid DNA (courtesy of Joseph Wu, Stanford University 17 ) was isolated using the plasmid Maxi-kit (Qiagen, Inc, CA). 293FT cells were then transfected. The supernatant was collected and centrifuged to obtain the pellets used for transduction.
Reporter Gene Virus Transduction
A total of 5×10 5 AMCs per 1-well were plated in 6-well plates 1 day before transduction. On the day of transduction, the cells were washed once with PBS and then incubated overnight in total volume of 250 mL of OptiMEM (Invitrogen) with BLI reporter gene virus pellets and 10 μg/mL of polybrene (Sigma, MO). BLI signal detected after 3 days assured effective transduction.
Virus Production and iPSC (MiPSC) Generation
The plasmid of pHAGE2EF1-OKSM (courtesy of G. Mostoslavsky, Boston University) was used to generate the virus.
14 293FT cells were then transfected. The virus was harvested for 3 days and concentrated by centrifugation. AMCs were transduced with the concentrated virus. These cells were then passaged on day 6 and cultured on plates preseeded with irradiated mouse fibroblasts. The cells were grown until the formation of spontaneous colonies.
Permanent Left Anterior Descending Artery Ligation
Animal care and interventions were done in accordance with the Laboratory Animal Welfare Act and all animals received humane care and treatment in accordance with the Guide for the Care and Use of Laboratory Animals (www.nap.edu/catalog/5140.html). Immunotolerant SCID (severe combined immunodeficiency)-beige male mice (90-120 days; Charles River Laboratories, Inc, MA) were anesthetized in an isofluorane inhalational chamber and endotracheally intubated with a 20-gauge angiocatheter (Ethicon Endo-Surgery, Inc, OH). Ventilation was maintained with a Harvard rodent ventilator (Harvard Apparatus, Inc, MA). Acute myocardial infarction was created by ligation of the mid-left anterior descending coronary artery through a left thoracotomy. The mice were randomly allocated to 4 groups. The mice received one of the following cell types or normal saline directly into the peri-infarct region immediately after induction of acute myocardial infarction: (1) normal saline control (n=9), (2) uAMCs (n=9), (3) c + AMCs (n=8), and (4) MiPSCs (n=9). The cells were injected into the peri-infarct region with a Hamilton syringe containing 250 000 cells suspended in a 20 μL volume of a 1:5 mixture of Matrigel (BD Biosciences, CA) and cell dissociation buffer (Sigma) to prevent clumping of cells. Cell dissociation buffer was used to prevent cell clumping. The chest was closed in 2 layers with 5-0 Vicryl suture (Ethicon). 15 Percent MEMRI scar volume=(MEMRI defect volume×100)/total LV mass volume; % MEMRI viable myocardial volume=(MEMRI enhancement volume×100)/total LV mass volume; % DEMRI scar volume=(DEMRI scar volume×100)/total LV mass volume; % DEMRI-MEMRI periinfarct volume=(DEMRI−MEMRI peri-infarct volume×100)/total LV mass volume.
In Vivo MRI

In Vivo Optical BLI
Optical BLI was performed 15 to 25 minutes after d-luciferin intraperitoneal injection (400 mg/kg; Xenogen, MA) with 3 to 5 minute acquisition scans on a charge-coupled device camera (IVIS 200; Xenogen). Peak signal from a fixed region of interest was evaluated with Living Image 3.2 software (Xenogen).
Immunohistology
Hearts were flushed with normal saline, fixed with paraformaldehyde, and embedded in paraffin blocks. A total of 4-μm slices were sectioned and then stained with hematoxylin and eosin.
Unstained paraffin embedded sections were deparaffinized and rehydrated. Sections underwent antigen unmasking, treatment with Triton-X 100 and blocking with BSA and normal goat serum. MiPSCs and c + AMCs of human origin were detected in murine myocardium using primary antibodies specific for human mitochondria. Primary antibodies specific for cardiomyocytes and endothelial cells were also detected using a goat anti-human IgG1 AlexaFluor 488 Ab. A rabbit polyclonal antibody to ckit was used and visualized with goat anti-rabbit IgG AlexaFluor 488. The cellular cytoskeleton was counterstained with AlexaFluor 568 Phalloidin. Finally, luciferin was immunostained by incubating rabbit anti-firefly luciferase and anti-human nuclear antigen and visualized with anti-rabbit AlexaFluor 488 and anti-mouse Cy3 secondary antibodies.
Luminex Immunoassay
The human 63-plex magnetic bead kit (eBiosciences/Affymetrix, CA) was used according to the manufacturer's recommendations with modifications as described below. Briefly, the beads were added to a 96-well plate and washed in a washer solution (BioTek ELx405, VT). Samples were added to the plate containing the mixed antibody-linked beads and incubated at room temperature for 1 hour followed by overnight shaking incubation at 4°C. Cold and room temperature incubation steps were performed on an orbital shaker at 500 to 600 rpm. After overnight incubation, the plates were washed and then biotinylated with detection antibody for 75 minutes at room temperature. The plate was washed as described above and streptavidin-PE was added. After incubation for 30 minutes at room temperature, another wash was performed and reading buffer was added to the wells. Fluorescence intensity of each sample was measured in duplicate. Plates were read using a Luminex 200 instrument with a lower bound of 50 beads per sample per cytokine. For quality control, custom assay control beads (Radix Biosolutions, TX) were added to all wells.
Real-Time Reverse Transcription Polymerase Chain Reaction
Total RNA was extracted from the 3 cell subpopulations (uAMCs, c + AMCs, and MiPSCs) using Trizol reagent (Invitrogen) according to the manufacturer's recommendation. A total of 2 00B5g of total RNA was transcribed into cDNA using Superscript first strand synthesis system (Invitrogen). The polymerase chain reaction (PCR) products were size fractionated by 2% agarose gel electrophoresis (Invitrogen). Genes were amplified using iQ SYBR Green Supermix (Applied Biosystems, MA) and StepOne Plus Real-Time PCR Detection System (Applied Biosystems). All genes were amplified for 40 cycles. Specific gene expression was first normalized to GADPH and then compared with control groups. Relative measurement for human primers was performed for the following: KLF4, NANOG, EBAF, MYC, SOX2, TDGF1, OCT4, GATA4, atrial natriuretic peptide (ANP), cardiac muscle troponin T (CTNT), cardiac muscle troponin I (CTNI), α-myosin heavy chain (α-MHC), NKX2.5 (Invitrogen). KLF4, NANOG, EBAF, MYC, SOX2, TDGF1, and OCT4 are previously described ESC pluripotency genes.
17 NKX2.5 and GATA4 are transcription factors associated with heart fieldspecific progenitors and embryonic cardiomyocytes, 18 whereas ANP, CTNT, CTNI, and α-MHC are mature cardiac-specific cell marker genes. 19, 20 In addition, total mRNA was isolated from the cell-treated and control myocardial tissue at the end of the study. Total mRNA was then reverse transcribed into cDNA. Real-time quantitative PCR was run on a 96-well real-time PCR thermocycler using Power SYBR Green master mix (Applied Biosystems), according to the manufacturer's recommendations. Relative measurement for mouse primers was performed for the following: collagen I, collagen III, connective tissue growth factor, transforming growth factor (TGF), fibronectin, and Akt. The GADPH housekeeping gene was used as reference for the relative quantification of the genes of interest.
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Telomerase Activity and Telomere Length
Telomerase activity was measured using the nonradioisotopic method of the TRAPeze Telomerase Detection kit (S7700; EMD Millipore, MA). The products were stained with SYBR Gold Nucleic Acid Gel Stain (Life Technologies, NY) and run on a 15% polyacrylamide gel in 1× TBE. Telomere length was measured by SpectraCell Laboratories, Inc (TX). Genomic DNA was extracted from 500 000 cells using phenol chloroform and quantified using the Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies). Telomere length analysis was performed at SpectraCell Laboratories Inc using a CLIA (clinical laboratory improvement amendments)-approved, high-throughput quantitative PCR assay. 22, 23 The assay determines a relative telomere length by measuring the factor by which the sample differs from a reference DNA sample in its ratio of telomere repeat copy number to singe gene (36B4) copy number. All samples were run in quadruplicate with ≥1 negative control and 2 positive controls of 2 different known telomere lengths (high and low). The results were reported as a telomere score equivalent to the average telomere length in kilo base pair.
Statistical Analysis
Results are mean±SEM. Significant differences (P<0.05) were tested using ANOVA and Bonferroni post-test for >2 groups or time points, and Student unpaired t test for 2 groups. The Pearson correlation coefficient was assessed between LVEF and viable myocardium by MEMRI, LVEF, and myocardial scar by DEMRI and LVEF and stem cell engraftment by BLI.
Results
LV Systolic Function Correlates With Stem Cell Engraftment
One week after acute myocardial infarction, all treated mice demonstrated improved LVEF compared with control ( Figure 1A ). However, the initial LVEF increase in the uAMC group (26.9±1.5% versus 17.9±0.2%, week 1; P<0.01) did not persist and was not significantly different from control (normal saline) at weeks 2 and 4. The initial functional improvement and subsequent decline paralleled the engraftment pattern of the transplanted uAMCs as measured by BLI ( Figure 2A 
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( Figure 2B ). Conversely, the MiPSC-treated mice had sustained improvement in LVEF throughout the 4 weeks compared with control (30.0±0.98% versus 19.0±1.3%, week 4; P<0.01; Figure 1B ). Furthermore, the MiPSC group demonstrated significantly greater improvement of LVEF when compared with the uAMC group. The MiPSC-mediated improvement in LVEF also paralleled the engraftment of the transplanted stem cells by BLI ( Figure 2C ). Finally, there was a nonsignificant trend toward decreased end-systolic volumes in the c + AMC and significant decrease in the MiPSC group compared with control (not shown). No significant difference in the end-diastolic volumes was seen between the treated and control groups.
MEMRI of Viable Myocardium and DEMRI of Infarct Scar
To quantify the contribution of the stem cells to the myocardium, myocardial viability was assessed directly by MEMRI and infarct scar by DEMRI. The uAMC-treated group had a significant increase in percent viable myocardial volume at week 1 compared with the control arm (85.6±0.6% versus 75.2±1.0%; P<0.01; Figure 3A ). However, this difference did not persist to week 4. Figure 3C ). These findings also paralleled the engraftment kinetics of c + AMCs. No significant difference in the DEMRI-MEMRI peri-infarct volumes was observed between the c + AMC and control groups at week 4 (9.8±3.2 versus 7.3±1.3; P=0.49).
However, the MiPSC arm demonstrated a significant and persistent increase in the direct MEMRI measurement of percent viable myocardial volume compared with the control arm throughout the 4-week period (89.1±0.7% versus 74.5±1.7%, week 4; P<0.01; Figure 3A and 3B). DEMRI scar volume was also significantly decreased compared with the control arm up to week 4 (21.4±1.3% versus 32.8±0.9%; P<0.01; Figure 3C ). These findings paralleled the sustained engraftment of MiPSCs. The peri-infarct volume, however, demonstrated no significant difference when compared with the controls (10.5±2.0% versus 7.3±1.3%; P=0.21).
Finally, significant correlation was found when analyzing the relationship between the 3 imaging parameters (MEMRI, BLI, and DEMRI) and functional restoration (LVEF) in the 3 treatment groups. Figure 4C and 4D) . However, immunohistology using anti-cardiac troponin T and anti-CD31 antibodies did not demonstrate evidence of cardiac 
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or endothelial differentiation, respectively ( Figure 4E and 4F) . The uAMC group did not demonstrate immunohistological evidence of engraftment. To confirm the origin of the BLI signal from the human cells, the MiPSCs were costained with antiluciferase antibody and human nuclear antibody ( Figure 4G ). Robust colocalization of the 2 immunostains confirms the origin of the BLI signal from the transplanted human stem cells. Of note, hematoxylin and eosin-stained sections of the myocardium demonstrated teratoma formation in all the mice in the MiPSC group as expected. The teratoma, however, were less invasive by gross histological visualization compared with our prior experience with murine and human ESCs ( Figure 5 ). There was no teratoma formation seen in the other groups.
Ex Vivo Analysis of Paracrine Factors
To better elucidate the myocardial salvage mechanism, the supernatant of each subpopulation underwent 63-plex Luminex Immunoassay of human cytokines. Significant differences in the production of 15 cytokines in the supernatant of MiPSCs and 10 cytokines in c + AMCs were detected when compared with uAMCs (P<0.05; Figure 6A ). The significant production of cytokines in the MiPSCs could be classified into the following categories: (1) Corresponding in vivo expression of molecular markers of apoptosis (Akt), fibrosis (collagen I, collagen III, connective tissue growth factor, TGF-β, and fibronectin), angiogenesis (VEGF), inflammation (TNF-α), and early cardiac differentiation (Nkx2.5) was measured at week 4 from the myocardial tissue in the 4 groups. Consistent with the Luminex assay, reverse transcriptase PCR demonstrated a trend toward increased expression of TNF-α in both MiPSC and c + AMC groups. In addition, NKX2.5 was significantly increased in the c + AMC group ( Figure 6B ).
Pluripotency, Telomerase Activity, and Telomere Length
Reverse transcriptase PCR was performed on MiPSCs, c + AMCs, and uAMCs ( Figure 7A c + AMCs to uAMCs. Furthermore, the telomerase activity and telomere length were measured for the 3 cell subpopulations. There was a significant increase in the telomerase activity for the MiPSC group, providing an additional parameter to explain for the prolonged engraftment. Telomere lengths were not significantly different for the 3 groups ( Figure 7B and 7C).
Discussion
Cardiomyocyte death or dysfunction after acute myocardial infarction results in pathological remodeling of the LV and eventual heart failure. Despite reports of restorative potential of cell-based therapies for the injured myocardium, real-time in vivo monitoring of regeneration of de novo myocardium or salvage of the in situ myocardium has not been possible. 16, 21, [24] [25] [26] In this study, we evaluated in vivo myocardial viability and stem cell engraftment directly to track the salvage of the injured myocardium using a novel multimodality imaging approach. Regeneration requires functional restoration, enhanced myocardial viability, and sustained engraftment with evidence of de novo cardiac differentiation. 8 Conversely, salvage requires functional restoration, enhanced myocardial viability, and engraftment signal without evidence of de novo cardiac differentiation. 8, 27 This study tested the salvage hypothesis that the enhanced stem cell engraftment will increase myocardial viability and restore the function of the injured myocardium. The 3 subpopulations derived from a common stem cell lineage were studied: (1) uAMCs, (2) c + AMCs, and (3) MiPSCs. These cells were transduced with luciferase reporter gene, which enabled reliable detection of stem cell engraftment by BLI. MEMRI and DEMRI were used to directly quantify myocardial viability and scar size. MEMRI uses the unique property of manganese (Mn 2+ ), which enters only the metabolically active, viable cells through voltage-gated calcium channel, and induces a T1-shortening effect to generate positive MRI contrast. This property complements DEMRI, which relies on nonspecific distribution of gadolinium in the extracellular space to delineate the scar. 15 The 3 AMC subpopulations demonstrated variable functional improvement of the injured myocardium during the 4-week period. In the uAMC-treated group, the initial recovery in function and viability was only seen transiently, which paralleled the nonengraftment or death of the transplanted stem cells. The c + AMC-treated mice demonstrated intermediate improvement in both LVEF and myocardial viability. Although these cells exhibited increased upregulation of NKX2.5, consistent with early cardiac progenitor phenotype, 28 significant functional improvement, myocardial viability, and cellular engraftment did not persist throughout the 4-week duration of the study. Sustained restoration was seen only in the MiPSC group, which exhibited significant increase in the viable myocardium by MEMRI and continued cell engraftment by BLI during all 4 weeks. This persistent increase in myocardial viability and cell engraftment without any evidence of cardiac differentiation in the MiPSC group is consistent with myocardial salvage as opposed to regeneration as the mechanism underlying sustained improvement in LVEF.
In support of salvage of the myocardium by the stem cells, the human cytokine 63-plex Luminex analysis demonstrated a significant increase in paracrine factors, including 15 anti-inflammatory, antiapoptotic, antifibrotic, and proangiogenic factors from the MiPSCs and 10 from the c + AMCs. Specifically, there were >9 factors (IL1B, TGF-β, IL9, TNF-α, ICAM1, VCAM1, FGF-B, PAl1, and ENA78), which MiPSCs expressed >2-fold increase when compared with c + AMCs. These findings were substantiated by the PCR analysis of the explanted myocardium, which exhibited a similar trend toward upregulation of the related genes. Specifically, TNF-α, a cytokine with multiple effects, which includes the antiapoptotic effects via activation of nuclear factor-κB, had increased signal by both cytokine and gene expression. 29 The sustained MiPSC engraftment and enhanced myocardial viability remained steady throughout the 4-week period, which most likely led to persistent paracrine effect to improve the LVEF. The findings that uAMCs show minimal while c + AMCs show intermediate evidence of salvage are consistent with our model that the decreased production of paracrine factors is commensurate with their limited engraftment. Finally, increased telomere activity was observed which does not necessarily correlate with telomere length. Telomere length is regulated by factors in addition to telomerase activity, [30] [31] [32] [33] including cis-acting regulators of association of telomerase with telomeres, 34 mitotic rate, and oxidative stress. 35 Telomere length is the net outcome of competing telomere shortening and lengthening events over the history of a cell lineage, and thus may not correlate with telomerase activity at 1 time point. iPSC-derived cells may have variable telomere length but the presence of increased telomerase activity in the MiPSCs provides definitive evidence of reprogramming of the cells. 30, 31 Based on these data, this study confirms that the MiPSCs enhance stem cell engraftment that leads to increased production of the paracrine factors to salvage the injured myocardium without any histological evidence of cardiac differentiation.
Limitation
The 3 cell subpopulations, derived from identical cell lineage, provided an optimal model to compare the restorative impact on the myocardium by stem cells with varying pluripotency states. However, the major limitation of this study is the absence of a MiPSC-derived cardiomyocytes. Because this study investigated the effect of stem cell engraftment and myocardial viability on the restorative potential of distinct cell types, the MiPSCs, which represent the highest pluripotency state, were selected to demonstrate myocardial salvage. Studies are underway to purify MiPSC-derived cardiomyocytes to assess the restorative potential of the differentiated cardiac cells when compared with the MiPSCs and their engraftment in an immunocompetent mice model. The teratoma formation by the MiPSCs is a clear contraindication to clinical use. However, additional experiments to understand the paracrine mechanism of the cell products derived from the MiPSCs are planned. The exosomes and their associated miRNAs will be identified to elucidate the underlying biological pathway in the production of the cytokines involved in myocardial salvage. The functional effects of the cytokines, their corresponding recombinant human analogs and small interfering RNAs, and the exosomes will be studied in preclinical animal models. If significant restoration is confirmed by these MiPSC derivatives, a potential clinical application of the MiPSCs may be to generate these cell products in vitro. In summary, the MiPSC-treated mice had sustained improvement in myocardial viability and LVEF compared with the uAMCs, c + AMCs, and control groups. These findings were coupled with sustained engraftment of MiPSCs, which enhanced the paracrine effects to salvage the injured myocardium. In contrast, the relatively modest improvements of the uAMC and c + AMC groups were attributed to limited engraftment and the subsequent attenuated release of paracrine factors, providing only transient enhancement of myocardial viability.
What Is Known?
• The mechanism of functional restoration with stem cell therapy remains poorly understood.
• The pluripotency states of the stem cell are thought to directly correlate with myocardial restoration potential after acute myocardial injury.
• Novel multimodality imaging using manganese-and delayed-enhanced MRI and bioluminescence imaging allows for serial in vivo evaluations of myocardial function and viability in relation to stem cell engraftment.
What New Information Does This Article Contribute?
• Amniotic mesenchymal stem cell-derived induced pluripotent stem cell demonstrated significantly greater increase in myocardial function and viability compared with the nonreprogrammed native populations of lesser cell potency.
• Improved myocardial function and viability correlated with the degree of stem cell engraftment.
• Amniotic stem cell-derived induced pluripotent stem cells demonstrated increased production of paracrine factors without evidence for cardiac or endothelial differentiation, consistent with myocardial salvage.
The underlying myocardial biology of functional restoration by stem cell therapy has been described as either regeneration or salvage of the injured myocardium. Using novel multimodality imaging with manganeseenhanced MRI, delayed-enhanced MRI and bioluminescence imaging, we demonstrate that amniotic stem cell-derived induced pluripotent stem cells-treated mice have a significant and sustained improvement in myocardial function and viability that are not seen in other amniotic stem cell-derived subpopulations of lesser cell potency. This correlated with the degree of stem cell engraftment by bioluminescence imaging. Further analyses demonstrated increased production of paracrine factors without evidence for cardiac or endothelial differentiation, consistent with myocardial salvage.
SUPPLEMENTAL MATERIAL Detailed Methods
Isolation of AMCs from Human Placentas.
A human placenta was obtained from one healthy subject, who provided a written informed consent, at the Stanford University Medical Center. The placenta was placed in HBSS media (Invitrogen, NY, USA) under sterile conditions. The human amniotic membrane from the placenta was separated from the chorion layer and then immediately washed 3 to 5 times with 0.9% NaCl solution to remove blood and mucus.
The membrane was cut into 2 x 2 cm pieces and transferred into an enzymatic digestion buffer containing trypsin-EDTA (Invitrogen) in phosphate-buffered saline and incubated at 37°C for 30 minutes. The digested tissue was centrifuged and the supernatant was discarded. Then, the tissue was subjected to a second enzymatic digestion in 50 ml of HBSS containing 50 mg type I collagenase (Invitrogen), 0.01% papain (Sigma, MO, USA) and 10% fetal bovine serum (Invitrogen) for 2 hours at 37 o C. After digestion, cells were washed 3 to 5 times and were collected by centrifugation at 200g for 5 minutes.
We called this heterogeneous population cells uAMCs. 
BLI Reporter Gene Virus Generation.
A BLI reporter gene plasmid DNA (courtesy of Joseph Wu, Stanford University 1 ) was isolated using the plasmid Maxi-kit (Qiagen Inc., CA, USA). 293FT cells were plated at a density of 5x10 6 . cells in 15 cm dish and grown in DMEM with 10% fetal bovine serum overnight, prior to transfection. All transfections were carried out using Fugene (Roche, Germany) according to the manufacturer's instructions. A total of 37 µg of BLI-reporter gene plasmid and 25 µg of pDM2G with 37.5 µg of PAX2 were used for each transfection. Approximately 48 hours after transfection, the supernatant was collected and centrifuged at 64000g for 2 hours. The pellets were suspended in 500 µL DMEM (Invitrogen) and used for transduction.
Virus Production and iPSC (MiPSC) Generation
The plasmid of pHAGE2EF1-OKSM (courtesy of G. Mostoslavsky, Boston University) was employed to generate the virus 2 . The 293FT cells were transfected at 90% confluence using lipofectamine (Invitrogen). For a 10 cm plate, 1 mL OptiMEM 
Immunohistology.
Hearts were flushed with normal saline solution and subsequently placed in 4% paraformaldehyde for 24 hours at room temperature, followed by 24 hours in 70%
ethanol at room temperature. The hearts were then embedded in paraffin blocks and sectioned in 4 µm slices. The slides were then stained with hematoxylin and eosin.
